Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
Reibman J, Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, Coyne KS, Murphy KR, George M. Reibman J, et al. Among authors: harding g. J Asthma Allergy. 2023 Jan 5;16:59-72. doi: 10.2147/JAA.S373184. eCollection 2023. J Asthma Allergy. 2023. PMID: 36636702 Free PMC article.
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
Chipps B, Zeiger RS, Beuther DA, Reibman J, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, George M, Murphy KR. Chipps B, et al. Among authors: harding g. Ann Allergy Asthma Immunol. 2023 Oct;131(4):436-443.e1. doi: 10.1016/j.anai.2023.04.024. Epub 2023 Apr 25. Ann Allergy Asthma Immunol. 2023. PMID: 37105501 Free article.
Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire.
Wise RA, Chipps B, Murphy KR, Beuther DA, Reibman J, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, George M, Zeiger RS. Wise RA, et al. Among authors: harding g. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3531-3533.e1. doi: 10.1016/j.jaip.2023.07.018. Epub 2023 Jul 19. J Allergy Clin Immunol Pract. 2023. PMID: 37474101 Free article. No abstract available.
Impact of Utilizing a Composite versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire.
Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Coyne KS, Harding G, Murphy KR. Chipps BE, et al. Among authors: harding g. J Asthma Allergy. 2024 Aug 7;17:751-756. doi: 10.2147/JAA.S461524. eCollection 2024. J Asthma Allergy. 2024. PMID: 39131600 Free PMC article. No abstract available.
Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control tool.
Lanz MJ, Chipps BE, Zeiger RS, Bacharier LB, Guilbert TW, Murphy KR, Winders T, Mohammad A, LeNoir M, Gilbert I, Eudicone JM, Coyne KS, Harding G, George M. Lanz MJ, et al. Among authors: harding g. Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01711-3. doi: 10.1016/j.anai.2024.11.021. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 39615584 Free article.
Validation of Constant Work Rate Cycling Endurance Time for Use in Chronic Obstructive Pulmonary Disease Clinical Trials.
Casaburi R, Merrill D, Leidy NK, Locantore N, Dolmage T, Garcia-Aymerich J, Goldstein R, Harding G, Maltais F, O'Donnell D, Porszasz J, Puente-Maestu L, Rennard S, Rossiter HB, Sciurba F, Spruit MA, Tal-Singer R, Tetzlaff K, Van't Hul A, Yu R, Hamilton A. Casaburi R, et al. Among authors: harding g. Ann Am Thorac Soc. 2024 May;21(5):727-739. doi: 10.1513/AnnalsATS.202305-480OC. Ann Am Thorac Soc. 2024. PMID: 38109693
583 results